Picture of enGene Therapeutics logo

ENGN enGene Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Forbion European Acquisition Says Further Extended Time Available To Consummate Its Business Combination From Sept 14 To Dec 14

Sept 13 (Reuters) - Forbion European Acquisition Corp
 FRBN.O :
    * FORBION EUROPEAN ACQUISITION CORP- FURTHER EXTENDED TIME
AVAILABLE TO CONSUMMATE ITS BUSINESS COMBINATION FROM SEPT 14 TO
DEC 14

Further company coverage:  FRBN.O 

 (Reuters.Briefs@thomsonreuters.com)

Recent news on enGene Therapeutics

See all news